Found: 74
Select item for more details and to access through your institution.
Outcomes of neoadjuvant chemoradiotherapy followed by total mesorectal excision surgery for locally advanced rectal cancer: a single-institution experience.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Strategies and Advancements in Harnessing the Immune System for Gastric Cancer Immunotherapy.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Systemic Therapy of Gastric Cancer—State of the Art and Future Perspectives.
- Published in:
- Cancers, 2024, v. 16, n. 19, p. 3337, doi. 10.3390/cancers16193337
- By:
- Publication type:
- Article
The topography of DNA methylation in the non-neoplastic colonic mucosa surrounding colorectal cancers.
- Published in:
- Molecular Carcinogenesis, 2014, v. 53, n. 2, p. 98, doi. 10.1002/mc.21951
- By:
- Publication type:
- Article
Real-world assessment of attenuated dosing anti-PD1 therapy as an alternative dosing strategy in a high-income country (as defined by World Bank).
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.932212
- By:
- Publication type:
- Article
Disruption of Her2-Induced PD-L1 Inhibits Tumor Cell Immune Evasion in Patient-Derived Gastric Cancer Organoids.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6158, doi. 10.3390/cancers13246158
- By:
- Publication type:
- Article
Whole Exome Sequencing of Multi-Regional Biopsies from Metastatic Lesions to Evaluate Actionable Truncal Mutations Using a Single-Pass Percutaneous Technique.
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1599, doi. 10.3390/cancers12061599
- By:
- Publication type:
- Article
FBXW5 Promotes Tumorigenesis and Metastasis in Gastric Cancer via Activation of the FAK-Src Signaling Pathway.
- Published in:
- Cancers, 2019, v. 11, n. 6, p. 836, doi. 10.3390/cancers11060836
- By:
- Publication type:
- Article
Novel SNP improves differential survivability and mortality in non-small cell lung cancer patients.
- Published in:
- BMC Genomics, 2014, v. 15, p. 1, doi. 10.1186/1471-2164-15-S9-S20
- By:
- Publication type:
- Article
Comprehensive profiling of DNA methylation incolorectal cancer reveals subgroups with distinctclinicopathological and molecular features.
- Published in:
- BMC Cancer, 2010, v. 10, p. 227, doi. 10.1186/1471-2407-10-227
- By:
- Publication type:
- Article
Upregulation of plasma C9 protein in gastric cancer patients.
- Published in:
- Proteomics, 2010, v. 10, n. 18, p. 3210, doi. 10.1002/pmic.201000127
- By:
- Publication type:
- Article
An Open‐Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM‐080301 in Subjects with Advanced Hepatocellular Carcinoma
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 747, doi. 10.1634/theoncologist.2018-0838
- By:
- Publication type:
- Article
Inhibition of MMP activity can restore NKG2D ligand expression in gastric cancer, leading to improved NK cell susceptibility.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 2, p. 380, doi. 10.1002/cncr.27758
- By:
- Publication type:
- Article
Validation of the functional assessment of cancer therapy-gastric module for the Chinese population.
- Published in:
- Health & Quality of Life Outcomes, 2012, v. 10, n. 1, p. 145, doi. 10.1186/1477-7525-10-145
- By:
- Publication type:
- Article
Anti-tumor efficacy of Selinexor (KPT-330) in gastric cancer is dependent on nuclear accumulation of p53 tumor suppressor.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-30686-1
- By:
- Publication type:
- Article
Upregulation of plasma C9 protein in gastric cancer patients.
- Published in:
- Proteomics - Clinical Applications, 2010, v. 4, n. 12, p. 967, doi. 10.1002/prca.201090106
- By:
- Publication type:
- Article
Resisting resistance to cancer immunotherapy.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 5, p. 507, doi. 10.1111/1759-7714.12614
- By:
- Publication type:
- Article
A phase 1 study of the safety, pharmacokinetics and pharmacodynamics of escalating doses followed by dose expansion of the selective inhibitor of nuclear export (SINE) selinexor in Asian patients with advanced or metastatic malignancies.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221087555
- By:
- Publication type:
- Article
Clinical outcome and prognostic factors for Asian patients in Phase I clinical trials.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 8, p. 1514, doi. 10.1038/s41416-023-02193-2
- By:
- Publication type:
- Article
DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Comparison of out-of-pocket costs and adherence between the two arms of the prospective, randomized abiraterone food effect trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Upregulation of thioredoxin-1 in activated human NK cells confers increased tolerance to oxidative stress.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 5, p. 605, doi. 10.1007/s00262-017-1969-z
- By:
- Publication type:
- Article
Unleashing the efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma: factors, strategies, and ongoing trials.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1261575
- By:
- Publication type:
- Article
FAM3C in circulating tumor-derived extracellular vesicles promotes non-small cell lung cancer growth in secondary sites.
- Published in:
- Theranostics, 2023, v. 13, n. 2, p. 621, doi. 10.7150/thno.72297
- By:
- Publication type:
- Article
Author Correction: PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Outcomes of a Phase II Study of Intraperitoneal Paclitaxel Plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases.
- Published in:
- 2023
- By:
- Publication type:
- Letter
ASO Author Reflections: Combination Intra-Peritoneal and Systemic Chemotherapy for Gastric Cancer with Peritoneal Metastases.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 13, p. 8606, doi. 10.1245/s10434-022-12102-1
- By:
- Publication type:
- Article
Knockdown of POLA2 increases gemcitabine resistance in lung cancer cells.
- Published in:
- BMC Genomics, 2016, v. 17, p. 87, doi. 10.1186/s12864-016-3322-x
- By:
- Publication type:
- Article
Low-Dose Nivolumab in Renal Cell Carcinoma: A Real-World Experience.
- Published in:
- Oncology, 2021, v. 99, n. 3, p. 192, doi. 10.1159/000512000
- By:
- Publication type:
- Article
Clinical translation of patient-derived tumour organoids- bottlenecks and strategies.
- Published in:
- Biomarker Research, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40364-022-00356-6
- By:
- Publication type:
- Article
Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres Followed by Gemcitabine plus Cisplatin for Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Single-Arm Multicenter Clinical Trial.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 5, p. 451, doi. 10.1159/000525489
- By:
- Publication type:
- Article
Systemic Treatment of Advanced Unresectable Hepatocellular Carcinoma after First-Line Therapy: Expert Recommendations from Hong Kong, Singapore, and Taiwan.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 5, p. 426, doi. 10.1159/000525582
- By:
- Publication type:
- Article
Molecular profiling of metastatic breast cancer and target-based therapeutic matching in an Asian tertiary phase I oncology unit.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1342346
- By:
- Publication type:
- Article
The role of pharmacogenetics in cancer therapeutics.
- Published in:
- British Journal of Clinical Pharmacology, 2006, v. 62, n. 1, p. 35, doi. 10.1111/j.1365-2125.2006.02591.x
- By:
- Publication type:
- Article
Diagnostic and Prognostic Utility of a DNA Hypermethylated Gene Signature in Prostate Cancer.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0091666
- By:
- Publication type:
- Article
Combination Therapy with Gossypol Reveals Synergism against Gemcitabine Resistance in Cancer Cells with High BCL-2 Expression.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0050786
- By:
- Publication type:
- Article
UGT1A6 Polymorphisms Modulated Lung Cancer Risk in a Chinese Population.
- Published in:
- PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0042873
- By:
- Publication type:
- Article
GTSE1 expression represses apoptotic signaling and confers cisplatin resistance in gastric cancer cells.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1550-0
- By:
- Publication type:
- Article
GTSE1 expression represses apoptotic signaling and confers cisplatin resistance in gastric cancer cells
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 550, doi. 10.1186/s12885-015-1550-0
- By:
- Publication type:
- Article
Methylation Subtypes and Large-Scale Epigenetic Alterations in Gastric Cancer.
- Published in:
- Science Translational Medicine, 2012, v. 4, n. 156, p. 1, doi. 10.1126/scitranslmed.3004504
- By:
- Publication type:
- Article
Pembrolizumab in Asian patients with microsatellite‐instability‐high/mismatch‐repair‐deficient colorectal cancer.
- Published in:
- Cancer Science, 2023, v. 114, n. 3, p. 1026, doi. 10.1111/cas.15650
- By:
- Publication type:
- Article
PD‐L1 expression is mainly regulated by interferon gamma associated with JAK‐STAT pathway in gastric cancer.
- Published in:
- Cancer Science, 2018, v. 109, n. 1, p. 43, doi. 10.1111/cas.13424
- By:
- Publication type:
- Article
Dose modifications in Asian cancer patients with hepatic dysfunction receiving weekly docetaxel: A prospective pharmacokinetic and safety study.
- Published in:
- Cancer Science, 2016, v. 107, n. 2, p. 173, doi. 10.1111/cas.12856
- By:
- Publication type:
- Article
Inhibition of mitogen-activated protein kinase pathway can induce upregulation of human leukocyte antigen class I without PD-L1-upregulation in contrast to interferon-γ treatment.
- Published in:
- Cancer Science, 2014, v. 105, n. 10, p. 1236, doi. 10.1111/cas.12503
- By:
- Publication type:
- Article
Krüppel-like factor 8 promotes cancer stem cell-like traits in hepatocellular carcinoma through Wnt/β-catenin signaling.
- Published in:
- Molecular Carcinogenesis, 2017, v. 56, n. 2, p. 751, doi. 10.1002/mc.22532
- By:
- Publication type:
- Article
miR-204 Inhibits Epithelial to Mesenchymal Transition by Targeting Slug in Intrahepatic Cholangiocarcinoma Cells.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2013, v. 32, n. 5, p. 1331, doi. 10.1159/000354531
- By:
- Publication type:
- Article
Tumour pharmacodynamics and circulating cell free DNA in patients with refractory colorectal carcinoma treated with regorafenib.
- Published in:
- Journal of Translational Medicine, 2015, v. 13, n. 1, p. 1, doi. 10.1186/s12967-015-0405-4
- By:
- Publication type:
- Article
Tumour pharmacodynamics and circulating cell free DNA in patients with refractory colorectal carcinoma treated with regorafenib.
- Published in:
- 2015
- By:
- Publication type:
- journal article
A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours.
- Published in:
- 2020
- By:
- Publication type:
- journal article